Porto-founded digital musculoskeletal (MSK) care unicorn (valuation $4 billion as of November 2025). Heartcore Capital (Copenhagen) is a named Nordic investor in Sword’s acquired Kaia Health platform (acquisition closed January 2026 for $285M).
Sword Health’s January 2026 acquisition of Kaia Health for $285 million brought a live German DiGA reimbursement code into the combined platform and pulled Heartcore Capital — Copenhagen-headquartered consumer-tech VC and historic Kaia backer — into the Sword cap table. The combined company is now profitable and positioned for the NordDEC single-accreditation pathway across Sweden, Denmark, Norway, Finland and Iceland.
Sword’s Nordic expansion via NordDEC is a textbook example of the corridor pattern that NorthSouth HQ tracks: a Portuguese-founded scale-up backed by Iberian and US capital, acquiring a German regulated-health platform that already had Nordic VC backing, then using a single Nordic accreditation framework to enter five public-health systems at once. Few Portuguese exporters have the regulatory positioning to follow this path; Sword Health is the most advanced live example in 2026.
On 28 January 2026 Sword Health completed the $285M acquisition of Kaia Health, integrating a live German DiGA reimbursement code and Kaia’s European footprint into the Sword platform. CEO Virgílio Bento told Bloomberg in the same window that the company was raising an additional $500M in Q1 2026 to fund further European expansion and potential bolt-ons. Heartcore Capital’s Copenhagen partnership remains an active investor in the combined entity via the Kaia legacy.
Fractio helps Portuguese B2B and industrial companies enter Sweden, Denmark, Norway and Finland — with local presence, without the overhead.
Talk to Fractio →